LncRNA GHET1 activated by H3K27 acetylation promotes cell tumorigenesis through regulating ATF1 in hepatocellular carcinoma.

[1]  Guo-Dong Lu,et al.  AKT activation was not essential for hepatocellular carcinoma cell survival under glucose deprivation , 2017, Anti-cancer drugs.

[2]  F. Slack,et al.  Targeting noncoding RNAs in disease , 2017, The Journal of clinical investigation.

[3]  Z. Dong,et al.  The protein level and transcription activity of activating transcription factor 1 is regulated by prolyl isomerase Pin1 in nasopharyngeal carcinoma progression , 2016, Cell Death and Disease.

[4]  Junming Guo,et al.  Roles of long noncoding RNAs in gastric cancer and their clinical applications , 2016, Journal of Cancer Research and Clinical Oncology.

[5]  Buning Tian,et al.  Knockdown of Long Noncoding RNA GHET1 Inhibits Cell Proliferation and Invasion of Colorectal Cancer. , 2016, Oncology research.

[6]  J. Zucman‐Rossi,et al.  Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers. , 2016, Advances in immunology.

[7]  Artemis G Hatzigeorgiou,et al.  Analyzing MiRNA-LncRNA Interactions. , 2016, Methods in molecular biology.

[8]  Zunnan Huang,et al.  Glabridin arrests cell cycle and inhibits proliferation of hepatocellular carcinoma by suppressing braf/MEK signaling pathway , 2016, Tumor Biology.

[9]  I. Zlobec,et al.  Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer , 2015, British Journal of Cancer.

[10]  Hui-yong Xu,et al.  lncRNA Expression Signatures in Periodontitis Revealed by Microarray: The Potential Role of lncRNAs in Periodontitis Pathogenesis , 2015, Journal of cellular biochemistry.

[11]  J. Bruix,et al.  Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta‐analysis , 2015, Hepatology.

[12]  T. Patel,et al.  Noncoding RNA as Therapeutic Targets for Hepatocellular Carcinoma , 2015, Seminars in Liver Disease.

[13]  O. Ortmann,et al.  Improving cancer care in Europe: Which institutional health structures might be beneficial and why? 1. European Roundtable Meeting (ERTM), 16th May 2014, Berlin, Germany , 2015, Journal of Cancer Research and Clinical Oncology.

[14]  Dake Chen,et al.  Long noncoding RNA GHET1 promotes the development of bladder cancer. , 2014, International journal of clinical and experimental pathology.

[15]  F. Chen,et al.  An Integrated Analysis of miRNA, lncRNA, and mRNA Expression Profiles , 2014, BioMed research international.

[16]  R. Kong,et al.  EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial–mesenchymal transition , 2014, Cell Death and Disease.

[17]  Cheng Huang,et al.  Long noncoding RNAs: Novel insights into hepatocelluar carcinoma. , 2014, Cancer letters.

[18]  Feng Yang,et al.  Long non‐coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c‐Myc mRNA stability , 2014, The FEBS journal.

[19]  Yunli Zhou,et al.  MEG3 noncoding RNA: a tumor suppressor. , 2012, Journal of molecular endocrinology.

[20]  A. Dimmler,et al.  The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. , 2008, Cancer research.

[21]  S. Hinrichs,et al.  Inhibition of tumor growth and metastasis of human melanoma by intracellular anti-ATF-1 single chain Fv fragment , 2000, Oncogene.